We defined 15.1% of MM patients as poor mobilizers; however, 69.0% of poor mobilizers had more than 1.0 × 106/kg CD34+ cells after multiple mobilizations, and up to two‐thirds of poor mobilizers subsequently underwent ASCT. The gene discussed is CD34; the disease is Miyoshi myopathy.